Mr. Akash Vikal | Nanotechnology and Advanced Materials | Innovative Research Award

IFTM University, Moradabad, India

Akash Vikal is an emerging pharmaceutical researcher specializing in pharmaceutics, nanomedicine, advanced drug delivery systems, and cancer therapeutics. His academic and research contributions primarily focus on the development of innovative formulation strategies designed to improve therapeutic efficacy, targeted delivery, and patient outcomes. Through extensive research in liposomal formulations, nanocarriers, gene delivery systems, and ocular therapeutics, he has established himself as a promising young contributor to modern pharmaceutical sciences.His research portfolio reflects interdisciplinary expertise integrating pharmaceutical technology, nanotechnology, oncology, ophthalmic therapeutics, and translational medicine. With numerous peer-reviewed publications, book chapters, and scientific presentations, he has actively contributed to advancing pharmaceutical innovation and drug delivery research.

Professional Profile

Education

Akash Vikal completed a Bachelor of Pharmacy (B.Pharm.) from Shri Gopichand College of Pharmacy with strong academic performance. He further pursued a Master of Pharmacy (M.Pharm.) in Pharmaceutics from ISF College of Pharmacy, where he specialized in advanced pharmaceutical formulation and drug delivery systems. His postgraduate research focused on the “Development and Characterization of Ferulic Acid and Docetaxel Loaded Liposomes Against Breast Cancer” under the guidance of Balak Das Kurmi.

Professional Experience

During his academic journey, Akash Vikal gained industrial exposure through internship training at HIS Pharmaceuticals Pvt. Ltd., where he developed practical knowledge related to pharmaceutical manufacturing and formulation processes. He has also actively contributed to scientific communication and peer-review activities, including reviewing submissions for reputed journals such as Dovepress journals Clinical Ophthalmology and Eye and Brain. In addition, he delivered an academic webinar on scientific writing and publication strategies for researchers and healthcare professionals.

Research Interest

He has contributed extensively to pharmaceutical and biomedical research through numerous publications in reputed international journals. His research covers areas such as metal-organic frameworks in drug delivery, PROTAC-based cancer therapy, nanoparticle-mediated antimicrobial strategies, CRISPR-assisted nanotechnology, nanocarrier systems for ocular therapeutics, and phytoconstituent-based anticancer therapies. Several of his works have been published in recognized journals including Applied Materials Today, Drug Delivery and Translational Research, AAPS PharmSciTech, Current Pharmaceutical Design, and Experimental Eye Research.

Award and Honor

Akash Vikal has received recognition for his academic and scientific contributions through participation in national and international conferences, workshops, and faculty development programs. He earned a Certificate of Excellence in Peer Reviewing for his contribution to academic quality enhancement. His involvement in intellectual property awareness programs, pharmaceutical research conferences, and specialized training workshops reflects his commitment to continuous professional development and scientific advancement.

Conclusion

Mebratu Tafesse Teferi demonstrates strong potential for the Best Researcher Award. His substantial academic qualifications, leadership experience, and dedication to educational research are commendable. His publications reflect significant contributions to Ethiopian education and leadership studies, making him a valuable candidate for the award. To further enhance his candidacy, Mebratu could focus on broadening his research scope, fostering international collaborations, and increasing his publication reach in globally recognized journals.

Publications Top Noted

Next-generation gene editing strategies in cancer: Integrating CRISPR, PROTACs, and advanced molecular technologies
Authors: Akash Vikal, Rashmi Maurya, Pradeep Kumar, Navneet Verma, Arun Kumar Mishra
Year: 2026
Liposomal Paclitaxel in Breast Cancer Therapy: Advances, Clinical Insights, and Future Perspectives
Authors: Akash Vikal, Rashmi Maurya, Navneet Verma, Arun Kumar Mishra
Year: 2026
A Mini-Review on Unlocking Cognitive Enhancement: An Innovative Strategy for Optimal Brain Functions
Authors: Akash Vikal, Rashmi Maurya, Brij Bihari Patel, Preeti Patel, Manish Kumar, Balak Das Kurmi
Year: 2025
Andrographis paniculata in Fatty Liver Disease: Mechanisms, Nanocarrier Approaches, and Therapeutic Potential
Authors: Akash Vikal, Rashmi Maurya, Preeti Patel, Balak Das Kurmi
Year: 2025
Development of Mucopenetrating Pegylated Liposomes Functionalized with Sodium Taurocholate for Enhanced Oral Insulin Delivery
Authors: Akash Vikal, Rashmi Maurya, Balak Das Kurmi, S. Jindal, R. K. Narang
Year: 2025
From Resistance to Response: Metallic Nanoparticles as Game Changers in Triple Negative Breast Cancer Therapy
Authors: Akash Vikal, Rashmi Maurya, Preeti Patel, R. K. Narang, Balak Das Kurmi
Year: 2025
Lutein as a Liver Guardian: Insights into its Hepatoprotective Mechanisms, Bioavailability, and Emerging Therapeutic Roles
Authors: Akash Vikal, Rashmi Maurya, Preeti Patel, Balak Das Kurmi
Year: 2025
Nanoemulsion Technology in Oral Drug Delivery: A Path to Enhanced Solubility and Bioavailability
Authors: Akash Vikal, Rashmi Maurya, Preeti Patel, Balak Das Kurmi
Year: 2025
Role of dePEGylation in Vesicular Carriers-Mediated Stimuli-Responsive Drug Delivery to Tumors
Authors: Akash Vikal, Rashmi Maurya, Abhinav Vashishat, Taqdir Singh, Satyam Khare, Preeti Patel, Balak Das Kurmi
Year: 2025

Dr. Renu Chaudhary | Microbiology | Best Researcher Award

CSIR-Institute of Genomics and Integrative Biology (IGIB), New Delhi | India

Dr. Renu Chaudhary is a dedicated microbiologist and molecular biologist with extensive expertise in genomics, genome editing (CRISPR/Cas9), and antifungal research. Her work spans transcriptomics, structural biology, phenotypic analysis, and the study of stress response mechanisms in pathogenic fungi and Mycobacterium tuberculosis. She has contributed significantly to isolating and characterizing antimicrobial bacteria from plant rhizospheres, developing novel antifungal compounds, and exploring molecular targets for antifungal and antibacterial therapeutics. Dr. Chaudhary has authored numerous peer-reviewed articles and book chapters, with a total of 156 citations, an h-index of 6, and an i10-index of 4, reflecting her research impact and scholarly recognition. She has been involved in leading and collaborating on several funded projects, including fellowships from national science agencies, focusing on fungal diagnostics, drug resistance mechanisms, and metal homeostasis in microbes. Her research interests include antifungal resistance, microbial genomics, protein therapeutics, and biotechnological applications of fungi. Recognized for excellence in presentations and publications, she has received awards for best poster and paper contributions at national and international conferences. Dr. Chaudhary combines deep scientific knowledge with analytical rigor, driving translational research aimed at innovative solutions for infectious disease management and microbial therapeutics.

Featured Publications

Chaudhary, R., Singh, B., Kumar, M., Gakhar, S. K., Saini, A. K., Parmar, V. S., … [et al.]. (2015). Role of single nucleotide polymorphisms in pharmacogenomics and their association with human diseases. Drug Metabolism Reviews, 47(3), 281–290.

Balhara, M., Chaudhary, R., Ruhil, S., Singh, B., Dahiya, N., Parmar, V. S., … [et al.]. (2016). Siderophores; iron scavengers: The novel & promising targets for pathogen specific antifungal therapy. Expert Opinion on Therapeutic Targets, 20(12), 1477–1489.

Ahlawat, S., Chaudhary, R., Dangi, M., Bala, K., Singh, M., Chhillar, A. K. (2020). Advances in tuberculous meningitis diagnosis. Expert Review of Molecular Diagnostics, 20(12), 1229–1241.

Chaudhary, R., Balhara, M., Jangir, D. K., Dangi, M., Dangi, M., Chhillar, A. K. (2019). In silico protein interaction network analysis of virulence proteins associated with invasive aspergillosis for drug discovery. Current Topics in Medicinal Chemistry, 19(2), 146–155.

Khatri, S., Kumar, M., Phougat, N., Chaudhary, R., Chhillar, A. K. (2016). Perspectives on phytochemicals as antibacterial agents: An outstanding contribution to modern therapeutics. Mini Reviews in Medicinal Chemistry, 16(4), 290–308.